Robb Knie - Jan 5, 2024 Form 4 Insider Report for Hoth Therapeutics, Inc. (HOTH)

Role
CEO and President, Director
Signature
/s/ Hayley Springer as Attorney-In-Fact for Robb Knie
Stock symbol
HOTH
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
4
Date filed
1/8/2024, 05:00 PM
Previous filing
Jul 18, 2023
Next filing
Aug 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOTH Options Award $0 +225K $0.00 225K Jan 5, 2024 Common Stock 225K $1.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.